AstraZeneca (AZNCF)
132.38
-7.42 (-5.31%)
At close: Apr 21, 2025, 3:52 PM
-5.31% (1D)
| Bid | 132.5 |
| Market Cap | 205.27B |
| Revenue (ttm) | 54.04B |
| Net Income (ttm) | 7.04B |
| EPS (ttm) | 4.5 |
| PE Ratio (ttm) | 29.42 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 139.85 |
| Volume | 1,641 |
| Avg. Volume (20D) | 1,973.4 |
| Open | 132.38 |
| Previous Close | 139.80 |
| Day's Range | 132.38 - 134.43 |
| 52-Week Range | 120.64 - 175.00 |
| Beta | 0.25 |
About AZNCF
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Feb 13, 2009
Employees 94,300
Stock Exchange PNK
Ticker Symbol AZNCF
Website https://www.astrazeneca.com